HOXA9 and cancer: To identify the target genes activated in MLL mutated recurrent group, some reported candidate targets (such as GATA4, GATA6, MMP2, MMP13, ETS1 and HOXA9) related to tumorigenesis, drug resistance and cancer progression were selected [28].